HIHO [HIGHWAY] 6-K:
[]
NCTY [The9] 6-K: The9 Singapore and a Solar Energy Company Signed
[The9 Singapore and a Solar Energy Company Signed a Partnership Agreement to Cooperate in Distribution of Solar Energy Using Blockchain Technology Shanghai, China, February 1, 2018 one-stop C&I is a joint venture company established in Singapore by Comtec Solar Systems Group Limited (HKSE: 00712) and]
ACH [ALUMINUM OF CHINA] 6-K: FORM 6-K Aluminum Corporation of China Limited People’s
[FORM 6-K Aluminum Corporation of China Limited People's Republic of China 100082 No. 62 North Xizhimen Street X Form 20-F X Yes 99.1 MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES Aluminum Corporation of China Limited Date February 2, 2018 By]
CHU [CHINA UNICOM (HONG KONG)] 6-K: Number 1 Announcement dated February 1, 2018 in
[Number 1 Announcement dated February 1, 2018 in respect of Voluntary Disclosure Commercial Pricing of the Lease of Telecommunications Towers and Related Assets From China Tower Corporation Limited. build-out the Companys ability to effectively sustain its growth and to achieve or enhance profit]
XRS [TAL Education] SC 13G: 13G CUSIP No.: 874080104 1. NAME OF REPORTING
[13G CUSIP No.: 874080104 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON VANGUARD WORLD FUNDS - VANGUARD INTERNATIONAL GROWTH FUND - 23-2471346 2. CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP A. B. X 3. SEC USE ONLY 4. CITIZENSHIP OF PLACE OF ORGANIZATION Delawar]
BSPM [Biostar Pharmaceuticals] 8-K: Our ref.: PS/SC/B397/AUD3/pp February 2, 2018 100F Street
[Our ref.: PS/SC/B397/AUD3/pp February 2, 2018 100F Street NE Washington DC Dear Sirs, We have read Item 4.0l (a) of Biostar Pharmaceuticals, Inc's Form 8-K, which discusses the resignation of Mazars CPA Limited as its independent registered public accounting firm, and we agree with the statements ma]
BSPM [Biostar Pharmaceuticals] 8-K: ______________ FORM 8-K ______________ CURRENT REPORT Date of
[______________ FORM 8-K ______________ CURRENT REPORT Date of Report (Date of earliest event reported): January 29, 2018 ______________ BIOSTAR PHARMACEUTICALS, INC. ______________ Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identificatio]
CHL [CHINA MOBILE] 6-K: Number Page 1.1 Voluntary Disclosure, dated February 1,
[Number Page 1.1 Voluntary Disclosure, dated February 1, 2018 A-1 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network expansion and capital expenditure plans; • the e]
BABA [Alibaba] 6-K: EXECUTION VERSION AMENDMENT TO SHARE AND ASSET PURCHASE
[EXECUTION VERSION AMENDMENT TO SHARE AND ASSET PURCHASE AGREEMENT Amendment THIS AMENDMENT TO THE SHARE AND ASSET PURCHASE AGREEMENT (this 浙江蚂蚁小微金融服务集团 股份 有限公司 浙江蚂蚁小微金融服务集团有限公司 浙江淘宝网 络 有限公司 杭州阿里 创业 投 资 有限公司 支付宝 中国 网络技术有限公司 杭州君澳股 权 投 资 合伙企 有限合伙 杭州君瀚股权投资合伙企业 有限合伙 Parties RECITALS WHEREAS, the Partie]
